The Princess Margaret Cancer Centre-Ontario Institute for Cancer Research Translational Genomics Lab (PM-OICR TGL) is a joint collaborative workspace located in the MaRS complex at University Avenue and College Street in downtown Toronto.
TGL enhances rapid access to genomics technologies, and facilitates genomic interpretation and reporting in clinical oncology. TGL provides research support to the Princess Margaret Cancer Centre and affiliated cancer research institutions as part of OICR’s Adaptive Oncology Program.MORE ABOUT US
Lab Sample Submissions & Costs
TGL specializes in sequencing and analysis methods for low input Formalin Fixed Paraffin Embedded (FFPE) cancer tissues.MORE ABOUT LAB SUBMISSIONS
PM-OICR TGL has developed optimized lab protocols for FFPE, fresh frozen tumor and plasma analytes for whole genome, whole transcriptome and targeted circulating tumor DNA based clinical profiling and annotation.
We use automated pipelines that follow GATK best practices. Contact firstname.lastname@example.org for further information about our processes.MORE ABOUT LAB METHODS
Dr. Trevor Pugh, Director of the OICR Genomics Program and TGL, works closely with Dr. Dax Torti, Project Manager and Dr. Jon Torchia, Manager Cancer Genome Interpretation, to facilitate numerous clinical genomics research initiatives.MORE ABOUT THE TEAM
Dr. Trevor Pugh
Director, OICR Genomics
Dr. Dax Torti
Project Manager, TGL
Dr. Jonathon Torchia
Dr. Dax Torti
PM-OICR Translational Genomics Lab
661 University Avenue
Toronto, Ontario M5G 0A3